[(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[(2R,3R,4S,5R,6S)-4,5-diacetyloxy-2-(acetyloxymethyl)-6-[2-(4-sulfamoylphenyl)ethylamino]sulfanyloxan-3-yl]oxyoxan-2-yl]methyl acetate

InChIKey	`QHBKLUUOXQAXFY-MEVVGGRJSA-N`
Compound Name	[(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[(2R,3R,4S,5R,6S)-4,5-diacetyloxy-2-(acetyloxymethyl)-6-[2-(4-sulfamoylphenyl)ethylamino]sulfanyloxan-3-yl]oxyoxan-2-yl]methyl acetate
Canonical SMILES	`CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](SNCCc3ccc(S(N)(=O)=O)cc3)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	7.73
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43570	CA12	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	7.9	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	7.9	pIC50	TTD_MultiTarget
Q16790	CA9	Homo sapiens	Human	PF00194	7.0	Ki	ChEMBL;BindingDB